1. Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer
   Ying Jiao et al, 2023, Frontiers in Oncology CrossRef
2. Screening and identification of genes associated with cell proliferation in cholangiocarcinoma
   Li Guo et al, 2020, Aging CrossRef
3. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network
   Yun Gong et al, 2022, BioMed Research International CrossRef
4. Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
   Jiaqi Hu et al, 2022, Frontiers in Oncology CrossRef
5. Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer
   E. Amiri Souri et al, 2021, British Journal of Cancer CrossRef
6. Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells
   Anna Egorova et al, 2021, Pharmaceuticals CrossRef
7. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers
   Leiming Fang et al, 2022, Genes CrossRef
8. Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma
   Terra G. Arnason et al, 2022, Cancers CrossRef
9. A pharmacognostic approach for mitigating pancreatic cancer: emphasis on herbal extracts and phytoconstituents
   Shruti Gupta et al, 2021, Future Journal of Pharmaceutical Sciences CrossRef
10. Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
    Ahyeon Kim et al, 2021, Nutrients CrossRef
11. The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors
    Fei Wu et al, 2021, Frontiers in Oncology CrossRef
12. Selected ideal natural ligand against TNBC by inhibiting CDC20, using bioinformatics and molecular biology
    Naimeng Liu et al, 2021, Aging CrossRef
13. Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention
    Chee Wai Fhu et al, 2021, Cancers CrossRef
14. Expression and Clinical Significance of Lactate Dehydrogenase A in Colon Adenocarcinoma
    Yutong Wang et al, 2021, Frontiers in Oncology CrossRef
15. The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases
    Gizem Celebi et al, 2020, International Journal of Molecular Sciences CrossRef
16. Phytochemistry and Pharmacological Activities of Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb
    Anzheng Nie et al, 2020, Frontiers in Pharmacology CrossRef
17. The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity
    Jiaqi Shi et al, 2022, Contrast Media & Molecular Imaging CrossRef
18. Prognostic evaluation and immune infiltration analysis of five bioinformatic selected genes in hepatocellular carcinoma
    Enjiang Lai et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
19. Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors
    Rajib Bhuniya et al, 2022, ACS Medicinal Chemistry Letters CrossRef
20. Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
    Zenghua Deng et al, 2021, Journal of Hepatocellular Carcinoma CrossRef
21. Current Progress and Perspectives of CDC20 in Female Reproductive Cancers
    Ke Ni et al, 2023, Current Molecular Medicine CrossRef